Literature DB >> 9640111

Development of the technology for 'Diprifusor' TCI systems.

J M Gray1, G N Kenny.   

Abstract

The availability of fast-acting intravenous drugs for anaesthesia has encouraged anaesthetists to gain a practical understanding of the pharmacodynamics and pharmacokinetics of these drugs to optimise their administration. 'Diprifusor' technology uses pharmacokinetic modelling to control the infusion rate of a pump, providing the anaesthetist with direct control of the blood concentration rather than indirect control by the infusion rate. The 'Diprifusor' electronics module is a dual microprocessor component that can be incorporated into an infusion pump to provide this mode of administration. This paper describes the module's infusion control system, prefilled syringe recognition system and the safety aspects addressed by the design.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9640111     DOI: 10.1111/j.1365-2044.1998.53s114.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  10 in total

Review 1.  Anaesthesia.

Authors:  A J Fox; D J Rowbotham
Journal:  BMJ       Date:  1999-08-28

Review 2.  Target-controlled infusion systems: role in anaesthesia and analgesia.

Authors:  M C van den Nieuwenhuyzen; F H Engbers; J Vuyk; A G Burm
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

3.  Individual indicators of appropriate hypnotic level during propofol anesthesia: highest alpha power and effect-site concentrations of propofol at loss of response.

Authors:  Hongling Kang; Hassan Mamdouh Hassan Mohamed; Masaki Takashina; Takahiko Mori; Yuji Fujino; Satoshi Hagihira
Journal:  J Anesth       Date:  2017-02-14       Impact factor: 2.078

4.  Drug-induced sleep endoscopy with target-controlled infusion using propofol and monitored depth of sedation to determine treatment strategies in obstructive sleep apnea.

Authors:  Clemens Heiser; Phillippe Fthenakis; Alexander Hapfelmeier; Sebastian Berger; Benedikt Hofauer; Winfried Hohenhorst; Eberhard F Kochs; Klaus J Wagner; Guenther M Edenharter
Journal:  Sleep Breath       Date:  2017-03-31       Impact factor: 2.816

5.  Individualizing propofol dosage: a multivariate linear model approach.

Authors:  Conceição Rocha; Teresa Mendonça; Maria Eduarda Silva; Pedro Gambús
Journal:  J Clin Monit Comput       Date:  2013-09-27       Impact factor: 2.502

6.  Comparison of Anesthesia-Controlled Operating Room Time between Propofol-Based Total Intravenous Anesthesia and Desflurane Anesthesia in Open Colorectal Surgery: A Retrospective Study.

Authors:  Wei-Hung Chan; Meei-Shyuan Lee; Chin Lin; Chang-Chieh Wu; Hou-Chuan Lai; Shun-Ming Chan; Chueng-He Lu; Chen-Hwan Cherng; Zhi-Fu Wu
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

7.  Comparative randomized study of propofol target-controlled infusion versus sevoflurane anesthesia for third molar extraction.

Authors:  Patrick K Chung; Parmanand Dhanrajani
Journal:  J Dent Anesth Pain Med       Date:  2018-06-29

8.  False selection of syringe-brand compatibility and the method of correction during target-controlled infusion of propofol.

Authors:  Yun-Jeong Chae; Jong-Yeop Kim; Do-Won Kim; Bong-Ki Moon; Sang-Kee Min
Journal:  Korean J Anesthesiol       Date:  2013-03-19

9.  Effects of sedation on subjective perception of pain intensity and autonomic nervous responses to pain: A preliminary study.

Authors:  Hongling Kang; Aya Nakae; Hiroshi Ito; Piyasak Vitayaburananont; Takehiro Minamoto; Takashi Ikeda; Mariko Osaka; Takashi Mashimo; Yuji Fujino; Satoshi Hagihira
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

10.  Moderate sedation induced by general anaesthetics disrupts audio-spatial feature binding with sustained P3 components in healthy humans.

Authors:  Takehiro Minamoto; Takashi Ikeda; Hongling Kang; Hiroshi Ito; Piyasak Vitayaburananont; Aya Nakae; Satoshi Hagihira; Yuji Fujino; Takashi Mashimo; Mariko Osaka
Journal:  Neurosci Conscious       Date:  2018-03-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.